14.84
price up icon1.02%   0.15
after-market Handel nachbörslich: 14.84
loading

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.63%
34.75
33.86 29.45 25.34 25.70
Operating Income/Loss
2.63%
-34.75
-33.86 -29.45 -25.34 -25.70
Income/Loss From Continuing Operations Before Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Income/Loss From Continuing Operations After Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Net Income/Loss
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Diluted Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Basic Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Diluted Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):